Article
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.
Pharmacogenetics - 1 Jun 1996
Lachman H M, Papolos D F, Saito T, Yu Y M, Szumlanski C L, Weinshilboum R M
Abstract excerpt
Catechol-O-methyltransferase (COMT) inactivates catecholamines and catechol drugs such as L-DOPA. A common genetic polymorphism in humans is associated with a three-to-four-fold variation in COMT enzyme activity and is also associated with individual variation in COMT thermal instability. We now...
Topics
- Catechol O-Methyltransferase
- Genotype
- Heterozygote
- Homozygote
- Humans
- Molecular Sequence Data
- Mood Disorders
- Pharmacogenetics
- Phenotype
- Polymorphism, Genetic
- Schizophrenia
